Assessing the Economic Value of Anticancer Therapies

With ever increasing demands on the constrained resources available for health care services, no one involved in decision making in health care can continue to ignore the economic costs of the services provided or the relative value for money offered by the available treatments. Economic evaluation has therefore become an important and indispensable tool for medical deci­ sion making, alongside the well-known methods for clinical eval­ uation. This is also true for cancer, despite the aura of sa